Align Technology (ALGN) is a publicly traded Healthcare sector company. As of May 21, 2026, ALGN trades at $160.49 with a market cap of $11.37B and a P/E ratio of 27.35. ALGN moved +5.34% today. Year to date, ALGN is +2.03%; over the trailing twelve months it is -10.52%. Its 52-week range spans $122.00 to $259.01. Analyst consensus is buy with an average price target of $203.27. Rallies surfaces ALGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Align Technology Holds $1.06B Cash, Expands Invisalign Sales Despite 1–2% ASP Decline: Align Technology holds $1.06 billion in cash and is expanding Invisalign clear aligner sales worldwide as iTero Lumina scanners lead its device mix. Management expects 2026 average selling prices to decline by 1–2% due to competitive pricing pressures.
| Metric | Value |
|---|---|
| Price | $160.49 |
| Market Cap | $11.37B |
| P/E Ratio | 27.35 |
| EPS | $5.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $259.01 |
| 52-Week Low | $122.00 |
| Volume | 1.22M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.10B |
| Net Income | $429.89M |
| Gross Margin | 67.57% |
11 analysts cover ALGN: 0 strong buy, 7 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $203.27.